Simple and choice reaction time performance in SIV-infected rhesus macaques

AIDS Research and Human Retroviruses

Volumn 15, Issue 6, 1999, Pages 571-583

  Marcario, Joanne K ^a   Raymond, Leigh A M ^a   McKiernan, Brian J ^a   Foresman, Larry L ^a   Joag, Sanjay V ^a   Raghavan, Ravi ^a   Narayan, Opendra ^a   Hershberger, Scott ^a   Cheney, Paul D ^a,b  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCEPT FORMATION; CONTROLLED STUDY; INFORMATION PROCESSING; MOTOR PERFORMANCE; NERVE INJURY; NEUROPSYCHOLOGICAL TEST; NONHUMAN; PRIORITY JOURNAL; RESPONSE TIME; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; TASK PERFORMANCE; VIRUS INFECTION; VIRUS VIRULENCE;

ANIMALS; MACACA MULATTA; MALE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS;

EID: 0033541463     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311097     Document Type: Article

References (32)

1. Janssen RS, Cornblath DR, Epstein LG, Foa RP, McArthur JC, Price RW, et al.: Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991;41:778-785.
2. Seilhean D, Duyckaerts C, Vazeux R, Bolgert F, Brunet P, Katlama C, Gentilini M, and Hauw JJ: HIV-1-associated cognitive/motor complex: Absence of neuronal loss in the cerebral neocortex. Neurology 1993;43:1492-1499.
3. Grant I, Heaton RK, Atkinson JH, Group H, and Center HNR: Neurocognitive disorders in HIV-1 infection. Curr Top Microbiol Immunol 1995;202:11-32.
4. Navia BA, Jordan BD, and Price RW: The AIDS dementia complex. I. Clinical features. Ann Neurol 1986;19:517-524.
5. Navia BA, Cho ES, Petito CK, and Price RW: The AIDS dementia complex. II. Neuropathology. Ann Neurol 1986;19:525-535.
6. Grunseit AC, Perdices M, Dunbar N, and Cooper DA: Neuropsychological function in asymptomatic HIV-1 infection: Methodological issues. J Clin Exp Neuropsychol 1994;16:898-910.
7. Miller EN, Satz P, and Visscher B: Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men. Neurology 1991;41:1608-1616.
8. Clifford DB, Jacoby RG, Miller JP, Seyfried WR, and Glicksman M: Neuropsychometric performance of asymptomatic HIV-infected subjects. AIDS 1990;4:767-774.
9. Law WA, Mapou RL, Roller TL, Martin A, Nannis ED, and Temoshok LR: Reaction time slowing in HIV-1-infected individual: Role of the preparatory interval. J Clin Exp Neuropsychol 1995;17:122-133.
10. Martin A, Heyes MP, Salazar AM, Kampen DL, Williams J, Law WA, Coats ME, and Markey SP: Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J Neuropsychiatry Clin Neurosci 1992;4:270-279.
11. Perdices M and Cooper DA: Simple and choice reaction time in patients with human immunodeficiency virus infection. Ann Neurol 1989;25:460-467.
12. Martin EM, Sorensen DJ, Edelstein HE, and Robertson LC: Decision-making speed in HIV-1 infection: A preliminary report. AIDS 1992;6:109-113.
13. Dunlop O, Bjorklund RA, Abdelnoor M, and Myrvang B: Five different tests of reaction time evaluated in HIV seropositive men. Acta Neurol Scand 1992;86:260-266.
14. Dunlop O, Bjorklund R, Abdelnoor M, and Myrvang B: Total reaction time: A new approach in early HIV encephalopathy? Acta Neurol Scand 1993;88:344-348.
15. Worth JL, Savage CR, Baer L, Esty EK, and Navia BA: Computer-based neuropsychological screening for AIDS dementia complex. AIDS 1993;7:677-681.
16. Karlsen NR, Reinvang I, and Froland SS: Slowed reaction time in asymptomatic HIV-positive patients. Acta Neurol Scand 1992; 86:242-246.
17. Karlsen NR, Reinvang I, and Froland SS: A follow-up study of neuropsychological function in asymptomatic HIV-infected patients. Acta Neurol Scand 1993;87:83-87.
18. Pequegnat W, Garrick NA, and Stover E: Neuroscience findings in AIDS: A review of research sponsored by the National Institute of Mental Health. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:145-170.
19. Joag SV, Adams RJ, Foresman L, Galbreath D, Zink MC, Pinson DM, McClure H, and Narayan O: Early activation of PBMC and appearance of antiviral CD8+ cells influence the prognosis of SIV-induced disease in rhesus macaques. J Med Primatol 1994;23: 108-116.
20. Joag SV, Adams RJ, Pinson DM, Adany I, and Narayan O: Intracerebral infusion of TNF-alpha and IL-6 failed to activate latent SIV infection in the brains of macaques inoculated with macrophage-tropic neuroadapted SIVmac. J Leukocyte Biol 1994; 56:353-357.
21. Sharma DP, Zink MC, Anderson M, Adams R, Clements JE, Joag SV, and Narayan O: Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: Pathogenesis of infection in macaques. J Virol 1992;66:3550-3556.
22. Marcario JK, Raymond LAM, McKiernan BJ, Joag SV, Foresman LL, Narayan O, and Cheney PD: Deficits in cognitive and motor performance in SIV infected rhesus macaques. Soc Neurosci Abstr 1996;22:941.
23. Joag SV, Adany I, Li Z, Foresman L, Pinson DM, Wang C, Stephens EB, Raghavan R, and Narayan O: Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: Intravaginal and oral disposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS. J Virol 1997;71:4016-4023.
24. Raghavan R, Cheney PD, Raymond LAM, Joag SV, Stephens EB, Adany I, Pinson DM, Li Z, Marcario JK, Jia FJ, Foresman LL, Berman NEJ, and Narayan O: Morphological correlates of neurological dysfunction in macaques infected with neurovirulent isolates of simian immunodeficiency virus. Neuropathol Appl Neurobiol 1999; in press.
25. Murray EA, Rausch DM, Lendvay J, Sharer LR, and Eiden LE: Cognitive and motor impairments associated with SIV infection in rhesus monkeys. Science 1992;255:1246-1249.
26. Eiden LE, Murray EA, and Rausch DM: Motor and cognitive functioning in nonhuman primates infected with simian immunodeficiency virus. In: Neuropsychohgy of HIV infection (Grant I and Martin A, eds.). Oxford University Press, New York, 1994, pp. 339-358.
27. Fox HS, Gold LH, Henriksen SJ, and Bloom FE: Simian immunodeficiency virus: A model for neuroAIDS. Neurobiol Dis 1997;4:265-274.
28. Marcario JK, Raymond LAM, McKiernan BJ, Foresman LL, Joag SV, Hershberger S, Raghavan R, Narayan O, and Cheney PD: Correlation of behavioral, physiological, virological and neuropathological variables associated with SIV infection in rhesus macaques. Soc Neurosci Abstr 1997;23:837.
29. Glass JD, Wesselingh SL, Seines OA, and McArthur JC: Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993;43:2230-2237.
30. Narayan O, Stephens EB, Joag SV, and Chelbloune Y: Animal models of human immunodeficiency virus neurological disease. In: AIDS and the Nervous System (Berger JR and Levy RM, eds.), 2nd Ed. Lippincott-Raven, Philadelphia, 1997, pp. 123-140.
31. Martin EM, Sorensen DJ, Robertson LC, Edelstein HE, and Chirurgi VA: Spatial attention in HIV-1 infection: A preliminary report. J Neuropsychiatry Clin Neurosci 1992;4:288-293.
32. Legallet E, Pons J-C, and Trouche E: Methods of motor performance evaluation: Application to a primate model for basal ganglia pathology. J Neurosci Methods 1994;55:79-87.